Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Non-Current Debt: 2022-2023

Historic Non-Current Debt for Gossamer Bio (GOSS) over the last 2 years, with Dec 2023 value amounting to $814,000.

  • Gossamer Bio's Non-Current Debt fell 93.21% to $814,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $814,000, marking a year-over-year decrease of 93.21%. This contributed to the annual value of $814,000 for FY2023, which is 93.21% down from last year.
  • As of Q4 2023, Gossamer Bio's Non-Current Debt stood at $814,000, which was down 77.60% from $3.6 million recorded in Q3 2023.
  • Over the past 5 years, Gossamer Bio's Non-Current Debt peaked at $29.2 million during Q1 2022, and registered a low of $814,000 during Q4 2023.
  • Moreover, its 2-year median value for Non-Current Debt was $10.6 million (2022), whereas its average is $11.7 million.
  • Data for Gossamer Bio's Non-Current Debt shows a maximum YoY plummeted of 93.21% (in 2023) over the last 5 years.
  • Quarterly analysis of 2 years shows Gossamer Bio's Non-Current Debt stood at $12.0 million in 2022, then tumbled by 93.21% to $814,000 in 2023.
  • Its last three reported values are $814,000 in Q4 2023, $3.6 million for Q3 2023, and $6.4 million during Q2 2023.